in vivo. The DNA binding domain is a nonspecific HMG domain, and introducing a point mutation into this domain gives rise to a mouse that suppresses the endogenous alleles and a phenotype very much like the loss of the Brg ATPase (84). In addition, mutations in SMARCE1 detected in patients with Coffin-Siris syndrome are also exclusive to the HMG domain (85).
